Viking Therapeutics, Inc. (VKTX): Weighted Average Diluted Shares
112.67M
Year ended 2025-12-31
+13.6%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 112.67M | +3.3% | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | 109.04M | +15.6% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | 94.35M | +22.8% | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | 76.83M | -0.5% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | 77.20M | n/a | 2024-02-07, From 2021-01-01 |